Rhodopsin phosphorylation in bovine rod outer segments is more sensitive to the inhibitory action of recoverin at the low rhodopsin bleaching than it is at the high bleaching  by Senin, Ivan I. et al.
FEBS 18579 FEBS Letters 408 (1997) 251-254 
Rhodopsin phosphorylation in bovine rod outer segments is more 
sensitive to the inhibitory action of recoverin at the low rhodopsin 
bleaching than it is at the high bleaching 
Ivan I. Senina, Aminullah A. Zargarovc, Muhammad Akhtarb, Pavel P. Philippova'* 
"Department of Enzymology, A.N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow 119899, Russia 
b Department of Biochemistry, University of Southampton, Basset Crescent East, Southampton, UK S09 3TU 
'Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Puschino, Moscow Region 142292, Russia 
Received 19 March 1997 
Abstract Recoverin, a calcium-binding protein, is supposed to 
have rhodopsin kinase as a target in the retinal rod cell. In the 
present work, we show that efficiency of recoverin as an inhibitor 
of rhodopsin phosphorylation in bovine rod outer segments is 
inversely proportional to the level of rhodopsin bleaching. These 
results, together with the data obtained previously in a 
reconstituted system (Senin et al. (1997) Biochem. J. 321, 551-
555), allow us to hypothesize that recoverin might be responsible 
for a Ca2+-dependent regulation of the kinase in vivo, preventing 
it from participating in the phosphorylation of unbleached 
rhodopsin. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The phosphorylation of bleached rhodopsm (Rho*) by rho-
dopsin kinase (RK) is commonly accepted to be responsible 
for the desensitization of the visual receptor, Rho* [1]. The 
overall process of the Rho* phosphorylation consists of two 
stages [2-6]: initially the kinase, present in an inactive state in 
the absence of Rho*, is converted into an active state (RK*) 
by interaction with Rho*; then Rho* which contains 9 poten-
tial sites for phosphorylation [7] is phosphorylated by RK*. It 
should be stressed that the kinase after being activated by 
Rho* also is capable of phosphorylating the non-bleached 
rhodopsin (Rho), although Rho is a much poorer substrate 
of the enzyme than is Rho* [4]. Due to the ability of RK* to 
phosphorylate Rho, the phosphate incorporation into rho-
dopsin, calculated per Rho*, can reach tens in reconstituted 
systems [4,8-10] or even hundreds in suspensions of electro-
permeabilized rod outer segments (ROSs) [11]. However, the 
physiological function of this phenomenon called 'high gain 
rhodopsin phosphorylation' [11] remains a mystery. 
In the reconstituted system the Ca2+-binding protein, recov-
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erin [12,13], which is supposed to have RK as the target [14-
16], inhibits high gain phosphorylation at high Ca2+ concen-
trations [8,10]. Besides there are indications that this high gain 
reaction is sensitive to Ca2+ in suspensions of electropermea-
bilized ROSs, being more active at nM than at mM Ca2+ 
levels (in review [17]). 
Our recent work [10] has suggested that high gain phos-
phorylation is, merely, a consequence of an unwanted side-
reaction, the conditions for which are created by the huge 
excess of Rho over Rho*, in ROS membranes, at low levels 
of illumination that corresponds to the normal working re-
gime of the retinal rod. Using a reconstituted system, we have 
found in [10] that recoverin inhibits the phosphorylation of 
Rho more effectively than it does that of Rho* and suggested 
that the preferential inhibition may be used in vivo to prevent 
the kinase from participating in a side-reaction of the Rho 
phosphorylation. Now, in developing the work [10], we have 
compared the sensitivity of Rho* and Rho phosphorylation to 
recoverin in ROS suspensions, i.e. under conditions which are 
closer to the in vivo situation than is the reconstituted system 
investigated earlier. 
2. Materials and methods 
[γ-32ΑΤΡ] was purchased from the Physicoenergetical Institute 
(Russia), all other chemicals were obtained through 'Sigma'. 
ROSs prepared from frozen retinae under dim red light [18] were 
frozen in liquid nitrogen and stored at —70°C. Rhodopsin concentra-
tion was determined by the difference in the optical densities of the 
samples at 500 nm before and after illumination in the presence of 
cetyltrimethyl ammonium bromide taking ε = 42 000 [19]. Recombi-
nant myristoylated recoverin [9] was used as a recoverin source; the 
protein concentrations were estimated by absorbance at 280 nm tak-
ing ε = 36400 [20]. SDS-PAGE was performed as described in [21]. 
[Ca2+]f was determined by using Ca2+-sensitive electrode [22]. 
RK, endogenously present in ROS aliquots, was assayed as de-
scribed in [10] at 30°C in the reaction mixture (50 ml) containing 20 
mM Tris-HCl (pH 7.4), 140 mM NaCl, 2 mM MgCl2, 500 μΜ [γ-
32ATP] (2.5 XlO4 cpm/nmol), 100 μΜ GTP, 10 μΜ rhodopsin in the 
content of ROS membranes (the corresponding concentration of en-
dogenous RK in the sample could be estimated as 0.01-0.1 μΜ [23]), 
1 mM EGTA or 1 mM EGTA+1.26 mM CaCl2 ([Ca
2-]f < 1 nM or 
200 μΜ respectively); 0-20 μΜ recombinant myristoylated recoverin 
(as indicated) and 50 mM NaF. The reaction was initiated by a light 
flash (percentage of rhodopsin bleaching as indicated) and the addi-
tion of ATP 30 s after the flash. At times shown in the figure legends 
aliquots were taken from the mixture and mixed with the SDS-PAGE 
sample buffer to stop the reaction. After SDS-PAGE of the samples, 
zones of rhodopsin were cut out and 32P incorporation was estimated 
by Cherenkov counting in plastic tubes; the counting level was 250-
30 000 cpm per sample from which the 'dark' level (80-150 cpm) was 
substrated in all cases. The data represented in Figs. 1-3 and Table 1 
are means ± S.D. of triplicate assays carried out on three occasions. 
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3. Results 
The initial increase of the 32P incorporation into rhodopsin 
in ROS suspensions is followed by its dephosphorylation 
which is more pronounced at 0.2% (Fig. 1A) than at 100% 
(Fig. IB) rhodopsin bleaching; the protein phosphatase inhib-
itor, NaF [24] fully arrests the dephosphorylation in both 
cases. Since the recoverin effect upon RK (but not upon the 
phosphatase [25]) has been our only interest in this work, all 
the subsequent experiments on the recoverin effect upon rho-
dopsin phosphorylation in the ROS suspension were per-
formed in the presence of NaF so that the rhodopsin phos-
phorylation would be determined by the kinase and not 
affected by the phosphatase. 
In the ROS suspension used in the present work, the max-
imal 32P incorporation into rhodopsin (calculated per mole 
Rho*) was equal to 1.4 and 35 at 100% and 0.2% rhodopsin 
bleaching, respectively (see Fig. 1); since the maximal incor-
poration in one Rho* molecule may not exceed 9 [7], it is clear 
that at least 26 P of 35 incorporated at the low bleaching 
represented the formation of the Rho-P. Direct quantitative 
determination of the Rho-P/Rho*-P ratio in the reconstituted 
system [10] has shown that at < 1% rhodopsin bleach, Rho-P 
Table 1 
Comparison of the half-times (/1/2) of rhodopsin phosphorylation in 
ROS suspensions at the high (100%) and the low (0.2%) rhodopsin 
bleaching 
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Fig. 1. Time dependence of the level of 32P incorporation into rho-
dopsin in ROS suspensions at 0.2% (A) and 100% (B) rhodopsin 
bleaching in the presence (·) or in the absence (o) of 50 mM NaF. 
[Ca2+]f = 200 μΜ; for other details of this and the following experi-
ments (Figs. 2 and 3 and Table 1) see Section 2. 
Conditions 




















The level of 32P incorporation into rhodopsin in ROS suspensions was 
measured in reaction mixtures (see Section 2), containing 50 mM NaF 
and 200 μΜ [Ca2+]f, in the presence or in the absence of recoverin at 
two levels of rhodopsin bleaching as indicated in the table. 
aii/2 is referred to as the reaction time whereby the total level of 32P 
incorporation into rhodopsin is equal to 1/2 of the maximal one. 
b'Recoverin effect' is referred to as the ratio of ίφ in the absence and 
in the presence of recoverin. 
was the main product whereas at a bleach level of > 5%, 
Rho*-P was almost the only phosphorylated species in the 
system. Although the data obtained in the reconstituted sys-
tem cannot be directly applied to ROS suspensions they allow 
us, if only qualitatively, to assume that in the suspension at 
bleaches much lower than 1% Rho-P predominates over 
Rho*-P; as for rhodopsin bleaches about 100%, the main 
(or the only) phosphorylated species is represented by Rho*-
P. An additional argument in favour of this assumption fol-
lows from the similarity of the plots '32P incorporation into 
rhodopsin vs. rhodopsin bleaching' in the ROS suspension 
(Fig. 2) and in the reconstituted system (compare with Fig. 
1 in [10]): in both cases the half-maximal incorporation man-
ifests at about 1% bleaching. 
The following experiments indicate that in a ROS suspen-
sion, recoverin inhibits phosphorylation of Rho more effec-
tively than it does that of Rho*. First, the recoverin addition 
caused an increase in the inhibition of the 32P incorporation 
into rhodopsin which was more pronounced at the low rho-
dopsin bleaching than at high bleaching (not shown). (With-
out recoverin addition, the level of 32P incorporation into 
rhodopsin at [Ca2+]f = 200 μΜ was approximately 25% lower 
than that at < 1 nM [Ca2+]f which could be explained by the 
presence of 'endogenous' recoverin in the ROS suspension [16] 
and possibly by the direct inhibitory action of the high Ca2+ 
concentration upon rhodopsin phosphorylation). Second, the 
plot '32P incorporation into rhodopsin vs. recoverin concen-
tration' was shifted towards lower recoverin concentrations as 
the rhodopsin bleaching decreased from 100% to 0.2% (Fig. 
3): the corresponding values for the half-maximal inhibitory 
concentration of recoverin were about 7 and 2.5 μΜ. Third, a 
comparison of the recoverin effect on the time course of Rho* 
and Rho phosphorylation in the presence of Ca2+ (Table 1) 
revealed a particularly striking difference: at the high bleach-
ing the effect was only 1.3-fold (the reaction half-time was 
14±3.5 and 11 ±4 min in the absence and in the presence 
of 5 μΜ recoverin respectively) whereas at the low bleaching 
a 12-fold effect was manifested (ti/2 decreased from 12 ±2 min 
to 1 ± 0.4 min as a result of recoverin addition). 
Therefore, one may conclude that rhodopsin phosphoryla-
tion in bovine ROS suspensions is more sensitive to the in-
hibitory action of recoverin at low rhodopsin bleachings, i.e. 
at the conditions under which Rho predominates over Rho*. 






















Fig. 2. Dependence of the total (D) and the relative (o) 32P incorporation into rhodopsin on rhodopsin bleaching in the ROS suspension. 
50 mM NaF and 200 μΜ [Ca2+]f were present, the reaction time was 40 min. 
4. Discussion 
The retinal rod cell can function as a quantum counter (in 
review [26]). Such a high sensitivity is reached due to the 
packing of rhodopsin molecules in the rod light antenna, 
ROSs to the unprecedented - for receptor proteins - concen-
tration in the range 0.1-1 mM (in review [27]). This should 
unavoidably create a problem for the Rho* turn-off mecha-
nism since the key enzyme involved in the process, RK will 
need to find and phosphorylate a few Rho* molecules in the 










Fig. 3. Dependence of 32P incorporation into rhodopsin in ROS sus-
pensions on recoverin concentration at 100% (o) and 0.2% (·) rho-
dopsin bleaching. 50 mM NaF and 200 μΜ [Ca2+]f were present, 
the reaction time was 40 min. The incorporation obtained in the ab-
sence of recoverin is taken as 100%. 
bleached receptors. Thus the possibility exists that RK, in 
spite of its preference for bleached rhodopsin compared to 
unbleached rhodopsin [4], may phosphorylate Rho in addition 
to Rho*. Indeed such a reaction does occur in vitro at low 
Ca2+ concentrations [8,10,17] and is responsible for the phe-
nomenon dubbed as high gain rhodopsin phosphorylation 
[11]. In isolated frog retina and in the retina of living frogs, 
however, under physiological light conditions only 1-2% of 
the total rhodopsin pool is phosphorylated [28]. If high gain 
rhodopsin phosphorylation observed in vitro also operated in 
vivo then a much higher pool of phosphorylated rhodopsin 
will be expected to be present (cf. [10]). This not being the case 
suggests the existence of a mechanism in vivo which prevents 
RK from the wasteful phosphorylation of Rho directing the 
kinase to fulfil its 'correct' function of Rho* desensitization. 
The results of this and our recent work [10] suggest that re-
coverin could serve such a role. 
Our working hypothesis on the in vivo role of recoverin is 
as follows. In the dark: Rho* and hence RK* are absent; RK 
is in a complex with recoverin due to high [Ca2+]f in the ROS 
cytoplasm. Upon illumination: Rho* appears and initiates the 
signal transduction; cytoplasmic [Ca2+]f decreases which fa-
vors the dissociation of the RK-recoverin complex; Rho* 
now binds RK and converts it into RK* which phosphoryl-
ates Rho*; the appearance of RK* creates conditions for Rho 
phosphorylation; recoverin competes with Rho for RK* (it is 
suggested that [Ca2+]f is high enough for this) and prevents 
RK* from catalyzing the Rho phosphorylation. 
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